ConductScience.org, home

Paper18831711

Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.

Lee TM and 3 others. Clin Sci (Lond), 2009. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Papers, record 18831711. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18831711

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
PubMed
Journal
Clin Sci (Lond)
PubMed
Year
2009
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
2.27
iCite
Revised in PubMed
2022-11-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee TMTsung-Ming
2Chen CCChien-Chang
3Shen HNHsiu-Nien
4Chang NCNen-Chung

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hydroxymethylglutaryl-CoA Reductase InhibitorsMajor topic
Hypertension, PulmonaryMajor topic
PravastatinMajor topic
Pulmonary Disease, Chronic ObstructiveMajor topic
Adult
Aged
Aged, 80 and over
Endothelin-1
Exercise Tolerance
Female
Hemodynamics
Humans
Lipids
Male
Middle Aged
Treatment Outcome

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in19037879Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease.https://conductscience.org/library/papers/19037879

Source PubMed

Download CSV of comments and corrections

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
41986588Low-density lipoprotein cholesterol and risk of COPD: a Mendelian randomization study.Sci Rep2026https://conductscience.org/library/papers/41986588PubMed
40963565Comparative effectiveness of statins for chronic obstructive pulmonary disease patients with pulmonary hypertension: systematic review and network meta-analysis.Front Med (Lausanne)2025https://conductscience.org/library/papers/40963565PubMed
39159048Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function.Clin Infect Dis2025https://conductscience.org/library/papers/39159048PubMed
37559605Effect of statins on pulmonary function in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.J Thorac Dis2023https://conductscience.org/library/papers/37559605PubMed
36799888Statin's role on blood pressure levels: Meta-analysis based on randomized controlled trials.J Clin Hypertens (Greenwich)2023https://conductscience.org/library/papers/36799888PubMed
35509841Simvastatin Inhibits NLRP3 Inflammasome Activation and Ameliorates Lung Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia via the KLF2-Mediated Mechanism.Oxid Med Cell Longev2022https://conductscience.org/library/papers/35509841PubMed
35198628Treatment of pulmonary hypertension associated with COPD: a systematic review.ERJ Open Res2022https://conductscience.org/library/papers/35198628PubMed
33765691Endothelin receptor antagonists for pulmonary arterial hypertension.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/33765691PubMed
33510638Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease.Front Pharmacol2020https://conductscience.org/library/papers/33510638PubMed
32080265Protective Effect of Statins on Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease Patients: A Nationwide Retrospective, Matched Cohort Study.Sci Rep2020https://conductscience.org/library/papers/32080265PubMed
32052074The bidirectional relationship between chronic obstructive pulmonary disease and coronary artery disease.Herz2020https://conductscience.org/library/papers/32052074PubMed
32042802Efficacy and safety of statin therapy in pulmonary hypertension: a systematic review and meta-analysis.Ann Transl Med2019https://conductscience.org/library/papers/32042802PubMed
31425628Statins versus placebo for people with chronic obstructive pulmonary disease.Cochrane Database Syst Rev2019https://conductscience.org/library/papers/31425628PubMed
30674312Effectiveness of long-term using statins in COPD - a network meta-analysis.Respir Res2019https://conductscience.org/library/papers/30674312PubMed
30282634Cardiovascular disease and COPD: dangerous liaisons?Eur Respir Rev2018https://conductscience.org/library/papers/30282634PubMed
30211239Trial of Atorvastatin on Serum Interleukin-6, Total Antioxidant Capacity, C-Reactive Protein, and Alpha-1 Antitrypsin in Patients with Chronic Obstructive Pulmonary Disease.J Res Pharm Pract2018https://conductscience.org/library/papers/30211239PubMed
29411315Inflammation Strikes Again: Frailty and HIV.Curr HIV/AIDS Rep2018https://conductscience.org/library/papers/29411315PubMed
29354804Are statins beneficial for the treatment of pulmonary hypertension?Chronic Dis Transl Med2017https://conductscience.org/library/papers/29354804PubMed
28932549Statins may be beneficial for patients with pulmonary hypertension secondary to lung diseases.J Thorac Dis2017https://conductscience.org/library/papers/28932549PubMed
28331863The Effects of Statins on Pulmonary Artery Pressure in Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.J Res Pharm Pract2017https://conductscience.org/library/papers/28331863PubMed

See all 40 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EDN11906PubTator's text mininghttps://conductscience.org/library/genes/1906

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18831711

GET https://conductscience.org/api/papers/v1/18831711/cited_by?page=2